Exercise for Peripheral Neuropathy
(CYCLE-CIPN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
CYCLE-CIPN is a proof-of-concept study designed to evaluate whether a prescribed aerobic exercise intervention has the potential to reduce the symptoms and functional impact of CIPN. The small number of participants in the proposed study will allow us to make decisions on the feasibility ("go/no-go") of a future larger-scale trial.
The protocol will assess feasibility and acceptability through recruitment, completion, adherence, program satisfaction, and safety. The study will also evaluate CIPN symptoms using both patient-reported and objective outcome measures, as well as fitness and quality of life outcomes. We aim to recruit 30 participants.
The Health Research Board of Alberta Cancer Committee has approved this study. Participants will participate in a stationary cycling-based aerobic exercise program biweekly for 12 weeks. Exercise sessions will be supervised and progressive, between 30 and 60 minutes each.
Who Is on the Research Team?
Margaret L McNeely, PhD
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cycling-Based Aerobic Exercise Intervention
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Cycling-based aerobic exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Margie McNeely
Lead Sponsor
University of Alberta
Lead Sponsor
Cross Cancer Institute
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.